Cargando…

Evaluation of non-pharmaceutical factors determine transmissibility of COVID-19: Useful insights and future challenges

Detalles Bibliográficos
Autor principal:	Tsuzuki, Shinya
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2020
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7508679/ https://www.ncbi.nlm.nih.gov/pubmed/34173600 http://dx.doi.org/10.1016/j.lanwpc.2020.100030

Ejemplares similares

Highly Effective Stratified Hub-and-Spoke Non-Pharmaceutical Intervention Provides New Insight into the Prevention of COVID-19 Transmission
por: Li, Hao, et al.
Publicado: (2020)

Effects of non-pharmaceutical interventions against COVID-19 on the incidence of other diseases
por: Müller, Olaf, et al.
Publicado: (2021)

The COVID-19 Pandemic: Global Asymmetries and Challenges for the Future of Health
por: Lima, Nísia Trindade, et al.
Publicado: (2021)

COVID-19 vaccinations in The Gambia: efforts, challenges, and future directions
por: Lowe, Mat, et al.
Publicado: (2022)

Benefits of COVID-19 non-pharmaceutical interventions on the prevention of other notifiable infectious diseases
por: Zhang, Qingpeng
Publicado: (2021)

Measles and Rubella during COVID-19 Pandemic: Future Challenges in Japan
por: Shimizu, Kazuki, et al.
Publicado: (2020)

An Evaluation of Local Pharmaceutical Manufacturing in Zimbabwe: How Prepared is Zimbabwe to Produce COVID-19 Vaccines?
por: Okereke, Melody, et al.
Publicado: (2022)

Antidotes, antibody-mediated immunity and the future of pharmaceutical product development
por: Caoili, Salvador Eugenio C.
Publicado: (2013)

Long-term care settings in the times of COVID-19: challenges and future directions
por: Ayalon, Liat, et al.
Publicado: (2020)

The impact of COVID-19 non-pharmaceutical interventions on future respiratory syncytial virus transmission in South Africa
por: Bents, Samantha, et al.
Publicado: (2022)

Heterogenous COVID-19 transmission dynamics within Singapore: a clearer picture of future national responses
por: Bagdasarian, N., et al.
Publicado: (2020)

Pharmaceutical policy Part 1 The challenge to pharmacists to engage in policy development
por: Morrow, Norman C
Publicado: (2015)

Physicians-Pharmaceutical Sales Representatives Interactions and Conflict of Interest: Challenges and Solutions
por: Patwardhan, Avinash R.
Publicado: (2016)

Pharmaceutical care of chloroquine phosphate in elderly patients with coronavirus pneumonia (COVID‐19)
por: Sun, Xuelin, et al.
Publicado: (2020)

The impact of COVID-19 on primary care: Insights from the National Health Service (NHS) and future recommendations
por: Mughal, Faraz, et al.
Publicado: (2021)

An insight into future antibacterial therapy
por: Cozzone, Alain J
Publicado: (2012)

Myoclonus and COVID‐19: A Challenge for the Present, a Lesson for the Future
por: Latorre, Anna, et al.
Publicado: (2020)

Grand Challenges, Covid‐19 and the Future of Organizational Scholarship
por: Howard‐Grenville, Jennifer
Publicado: (2020)

Preparing for a future COVID-19 wave: insights and limitations from a data-driven evaluation of non-pharmaceutical interventions in Germany
por: Aravindakshan, Ashwin, et al.
Publicado: (2020)

Non-COVID-19 UK clinical trials and the COVID-19 pandemic: impact, challenges and possible solutions
por: Lorenc, Ava, et al.
Publicado: (2023)

A step towards gender equity to strengthen the pharmaceutical workforce during COVID-19
por: Bukhari, Nadia, et al.
Publicado: (2020)

COVID-19’s impact on neglected pharmaceutical staff: wake-up call for needed research
por: Powell, Richard Antony, et al.
Publicado: (2021)

The role of professional socialisation in reducing drug-related problems during COVID-19: a new insight for future pandemics
por: Al Meslamani, Ahmad Z.
Publicado: (2022)

The need for a functional pharmaceutical industry in Sierra Leone: lessons from the COVID-19 pandemic
por: Conteh, Eugene, et al.
Publicado: (2022)

Evaluating the impacts of non-pharmaceutical interventions on the transmission dynamics of COVID-19 in Canada based on mobile network
por: Xue, Ling, et al.
Publicado: (2021)

The Pharmaceutical Sciences in 2020: Report of a Conference Organized by the Board of Pharmaceutical Sciences of the International Pharmaceutical Federation (FIP)
por: Shah, Vinod P., et al.
Publicado: (2010)

COVID-19 and the future of clinical epidemiology
por: Armstrong, Katrina, et al.
Publicado: (2021)

The need to consider social and cultural factors when reporting successful non-hospital transmission strategies for COVID-19
por: Kuchinski, Ann Marie, et al.
Publicado: (2021)

Evaluating diagnostic tests during outbreaks: challenges and lessons learnt from COVID-19
por: Escadafal, Camille, et al.
Publicado: (2023)

COVID-19: asymptomatic carrier transmission is an underestimated problem
por: Zhao, Hongjun, et al.
Publicado: (2020)

Nanomedicine: promises and challenges for the future of public health
por: Pautler, Michelle, et al.
Publicado: (2010)

Postdigital Research: Genealogies, Challenges, and Future Perspectives
por: Jandrić, Petar, et al.
Publicado: (2022)

Visual object tracking: Progress, challenge, and future
por: Zhang, Libo, et al.
Publicado: (2023)

Challenges and Controversies to Testing for COVID-19
por: Binnicker, Matthew J.
Publicado: (2020)

The challenges of distributing COVID-19 vaccinations
por: Mills, Melinda C., et al.
Publicado: (2020)

COVID‐19 environmental transmission and preventive public health measures
por: Vardoulakis, Sotiris, et al.
Publicado: (2020)

Commentary: Exploring the transmission of COVID-19 through the ocular surface
por: Joseph, Joveeta
Publicado: (2020)

COVID 19: Health care workers, risks, protection and transmission
por: Leeds, Clare
Publicado: (2020)

The precision of epidemiological investigation of COVID-19 transmission in Shanghai, China
por: Shi, Ying, et al.
Publicado: (2021)

Pharmaceutical Policy Part 2 Pharmaceutical engagement and policy development: a framework for influence
por: Morrow, Norman C
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_fb64gn1givhfd6b8t44u1l4bjb